EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic epidemiology of SARS-CoV-2 in Bolivia, 2020–2024

Esdenka Pérez-Cascales, Francesca Caballero iD, Anne Martínez-Ventura, Brenda Ayzanoa, Mauricio Prado-Zapata, Eliana Baldiviezo-Soliz, Paula Carballo-Jiménez, Freddy Tinajeros-Guzmán, Diego Cuicapuza, Pablo Tsukayama iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.01280-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Esdenka Pérez-Cascales und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Diagnóstico e Investigación BIOSCIENCE SRL, Santa Cruz, Bolivia. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica, Fogarty International Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic has severely impacted Bolivia due to its high social vulnerability and limited healthcare resources. In response to the limited local capacity for genomic surveillance during the pandemic, we characterized the genetic diversity and geographic distribution of SARS-CoV-2 variants across Bolivia from 2020 to 2024. A total of 714 SARS-CoV-2 genomic sequences were analyzed, including 313 newly sequenced samples and 401 retrieved from GISAID, allowing us to track viral evolution across six epidemic waves. The first wave, dominated by the Wuhan B.1 lineage, resulted in 8,943 deaths, while the fourth wave, characterized by the Omicron BA variant, had the highest infection rates, with approximately 80,000 confirmed cases. While mortality decreased in later waves, case numbers remained high due to the emergence of variants with increased transmissibility and immune escape. Our findings underscore the dynamic evolution of SARS-CoV-2 in Bolivia and highlight the critical need for sustained genomic surveillance to monitor emerging variants and inform public health strategies, particularly in resource-limited settings. Strengthening genomic surveillance, especially in cross-border regions, will mitigate future epidemic waves and improve pandemic preparedness. IMPORTANCE Bolivia’s response to the COVID-19 pandemic was challenged by a fragile healthcare system and high social vulnerability. Despite early containment measures, including strict quarantine, the virus spread widely, leading to multiple epidemiological waves that strained the healthcare system and caused significant economic disruption. In this context, genomic surveillance is essential for understanding the evolution of SARS-CoV-2, identifying emerging variants, tracking transmission patterns, and evaluating mitigation strategies. Our study comprehensively analyzes viral dynamics in Bolivia, identifying key transmission hubs and variant replacements across six epidemic waves. These findings underscore the importance of sustained genomic surveillance in resource-limited settings, where real-time monitoring is crucial to anticipate epidemiological trends and enhance pandemic preparedness. Strengthening genomic surveillance capabilities will enhance Bolivia’s ability to respond to future health crises and contribute to regional and global pandemic surveillance efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2BoliviaHumansGenome, ViralPhylogenyGenetic VariationGenomicsMolecular Epidemiology

Stichwörter der Autor:innen

SARS-CoV-2molecular epidemiologyphylogenetics

Autor:innen und Institutionen

  • Laboratorio de Diagnóstico e Investigación BIOSCIENCE SRL, Santa Cruz, Bolivia.
  • Laboratorio de Genómica Microbiana, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Emerge (Emerging Diseases and Climate Change Research Unit), Facultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Asociación Benéfica PRISMA, Santa Cruz, Bolivia.
  • Department of Infectious Disease, IFHAD: Innovation For Health And Development, Imperial College London, London, United Kingdom.
  • Department of Tropical Medicine and Infectious Disease, Tulane University, New Orleans, Louisiana, USA.

ORCID-Profile: Francesca Caballero, Pablo Tsukayama

Förderung

  • FIC NIH HHS
  • Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica
  • Fogarty International Center

Zitieren

APA

Pérez-Cascales, E., Caballero, F., Martínez-Ventura, A., Ayzanoa, B., Prado-Zapata, M., Baldiviezo-Soliz, E., Carballo-Jiménez, P., Tinajeros-Guzmán, F., Cuicapuza, D., & Tsukayama, P. (2025). Genomic epidemiology of SARS-CoV-2 in Bolivia, 2020–2024. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01280-25

Vancouver

Pérez-Cascales E, Caballero F, Martínez-Ventura A, Ayzanoa B, Prado-Zapata M, Baldiviezo-Soliz E, et al. Genomic epidemiology of SARS-CoV-2 in Bolivia, 2020–2024. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01280-25

BibTeX
@article{PrezCascales2025,
  author = {Pérez-Cascales, Esdenka and Caballero, Francesca and Martínez-Ventura, Anne and Ayzanoa, Brenda and Prado-Zapata, Mauricio and Baldiviezo-Soliz, Eliana and Carballo-Jiménez, Paula and Tinajeros-Guzmán, Freddy and Cuicapuza, Diego and Tsukayama, Pablo},
  title = {Genomic epidemiology of SARS-CoV-2 in Bolivia, 2020–2024},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.01280-25}
}
Kostenlos starten →